| Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies. MBJ Yadava K, Pattaroni C, Sichelstiel AK, Trompette A, Gollwitzer ES ... Am J Respir Crit Care Med, 2015 | 163* | 2015 |
| Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract C Pasquali, O Salami, M Taneja, ES Gollwitzer, A Trompette, C Pattaroni, ... Frontiers in medicine 1, 41, 2014 | 87 | 2014 |
| Microbiome influences on allergy in mice and humans BJ Marsland, O Salami Current Opinion in Immunology 36, 94–100, 2015 | 61 | 2015 |
| Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation A Sichelstiel, K Yadava, A Trompette, O Salami, Y Iwakura, LP Nicod, ... PloS one 9 (6), e98440, 2014 | 47 | 2014 |
| The human microbiota and chronic disease: dysbiosis as a cause of human pathology L Nibali, B Henderson John Wiley & Sons, 2016 | 35 | 2016 |
| Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation BM Ariadna Nebot Giralt, Christiana Nöstlinger, Janice Lee, Olawale Salami ... BMJ Open 7 (3), www.bmjopen.bmj.com/content/7/3/e0145, 2017 | 21* | 2017 |
| Has the airway microbiome been overlooked in respiratory disease? O Salami, BJ Marsland Genome medicine 7, 1-3, 2015 | 15 | 2015 |
| Impact of a package of diagnostic tools, clinical algorithm, and training and communication on outpatient acute fever case management in low-and middle-income countries … O Salami, P Horgan, CE Moore, A Giri, A Sserwanga, A Pathak, B Basnyat, ... Trials 21, 1-13, 2020 | 14 | 2020 |
| Assessing the adoption of lopinavir/ritonavir oral pellets for HIV‐positive children in Zimbabwe B Pasipanodya, R Kuwengwa, ML Prust, B Stewart, C Chakanyuka, ... Journal of the International AIDS Society 21 (12), e25214, 2018 | 13 | 2018 |
| Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation A Nebot Giralt, C Nöstlinger, J Lee, O Salami, M Lallemant, ... PLoS One 14 (8), e0220408, 2019 | 9 | 2019 |
| High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan O Salami, A Buzu, C Nzeme Journal of the International AIDS Society 13 (Suppl 4), P123, 2010 | 6 | 2010 |
| Impact of the introduction of a package of diagnostic tools, diagnostic algorithm, and training and communication on outpatient acute fever case management at 3 diverse sites … J Kapisi, A Sserwanga, FE Kitutu, E Rutebemberwa, P Awor, S Weber, ... Clinical Infectious Diseases 77 (Supplement_2), S156-S170, 2023 | 4 | 2023 |
| Impact of Point-of-Care Rapid Diagnostic Tests on Antibiotic Prescription Among Patients Aged< 18 Years in Primary Healthcare Settings in 2 Peri-Urban Districts in Ghana … A Adjei, V Kukula, CT Narh, S Odopey, E Arthur, G Odonkor, MM Mensah, ... Clinical Infectious Diseases 77 (Supplement_2), S145-S155, 2023 | 4 | 2023 |
| 842-EFFECTIVENESS AND SAFETY OF LPV/R PELLETS-BASED ART IN CHILDREN: 48-WEEK ANALYSIS I Andrieux-Meyer, O Salami, R Omollo, T Egondi, V Musiime, D Wamalwa, ... | 4 | 2018 |
| Pellets' formulation of lopinavir/ritonavir in children: 48-week evolution of viral suppression across age categories in the living study I Andrieux-Meyer, O Salami, R Omollo, T Egondi, M Waweru, S Odiambo, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 21, 38-38, 2018 | 3 | 2018 |
| Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa P Olliaro, J Nkeramahame, O Salami, CE Moore, P Horgan, R Baiden, ... Clinical Infectious Diseases 77 (Supplement_2), S125-S133, 2023 | 2 | 2023 |
| A randomized trial to assess the impact of a package of diagnostic tools and diagnostic algorithm on antibiotic prescriptions for the management of febrile illnesses among … F Kiemde, D Valia, B Kabore, T Rouamba, AN Kone, S Sawadogo, ... Clinical Infectious Diseases 77 (Supplement_2), S134-S144, 2023 | 2 | 2023 |
| The microbiota and susceptibility to asthma O Salami, BJ Marsland The Human Microbiota and Chronic Disease: Dysbiosis as a Cause of Human …, 2016 | 1 | 2016 |
| The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal: a qualitative study S Udas, OB Chand, B Shrestha, S Pathak, S Syantang, A Dahal, A Karkey, ... BMC Public Health 24 (1), 1219, 2024 | | 2024 |
| Knowledge and Prevalence of Pelvic Floor Disorders Among Women Attending Outpatient Clinics in South West Nigeria: A Questionnaire-Based Survey F Akinlusi, O Salami INTERNATIONAL UROGYNECOLOGY JOURNAL 34, S235-S235, 2023 | | 2023 |
Koshika YadavaVector BiopharmaVerified email at vectorbiopharma.com
